Adial Pharmaceuticals Appoints Matthew Davidson as President and CEO
Position
Chief Executive Officer
Company
Azora Therapeutics, Inc. (DE)
EncinoBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalDescription
Adial Pharmaceuticals is set to make significant leadership changes after its 2026 Annual Meeting. Matthew Davidson, currently Chief Development Officer, is expected to be appointed as the new President and CEO, while Vinay Shah will be terminated as CFO.
Quick answer
Adial Pharmaceuticals Appoints Matthew Davidson as President and CEO (August 29, 2026). Azora Therapeutics, Inc. (DE) is based in Encino, California, United States.
- Who is the new Chief Executive Officer at Azora Therapeutics, Inc. (DE)?
- Azora Therapeutics, Inc. (DE) named Matthew Davidson Chief Executive Officer, announced August 29, 2026.
- What did Azora Therapeutics, Inc. (DE) announce on August 29, 2026?
- Adial Pharmaceuticals is set to make significant leadership changes after its 2026 Annual Meeting. Matthew Davidson, currently Chief Development Officer, is expected to be appointed as the new President and CEO, while Vinay Shah will be terminated as CFO.
- Where is Azora Therapeutics, Inc. (DE) based?
- Azora Therapeutics, Inc. (DE) is based in Encino, California, United States.
- Which similar companies made leadership changes around the same time?
- Parabilis Medicines (August 25, 2026), Retension Pharmaceuticals (September 10, 2026), Olema Pharmaceuticals, Inc. (August 13, 2026) and Aquestive Therapeutics, Inc. (September 29, 2026) also announced leadership changes within 45 days of Azora Therapeutics, Inc. (DE).
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Parabilis Medicines Appoints Craig Tendler as Director (August 25, 2026)
- Retension Pharmaceuticals Appoints LeAnne Bloedon as EVP of Clinical Development (September 10, 2026)
- Olema Pharmaceuticals Appoints Jason O’Byrne as Chief Financial Officer (August 13, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer (September 1, 2026)
Who to call at Azora Therapeutics, Inc. (DE), and when
A new leader at Azora Therapeutics, Inc. (DE) brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Azora Therapeutics, Inc. (DE) raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Azora Therapeutics, Inc. (DE), from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Azora Therapeutics, Inc. (DE). With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Azora Therapeutics, Inc. (DE) changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Azora Therapeutics, Inc. (DE) changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.